Trials / Completed
CompletedNCT03195608
Using Advanced Driver Assistance Systems (ADAS) as an Intervention Strategy for Drivers With Parkinson's Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Western University, Canada · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Parkinson's disease (PD) impacts an individual's fitness to drive in a number of ways that increase the crash risk in this population. Current vehicle automation technologies are available, that although designed for the general public, may help drivers with PD stay on the roads longer and safer than currently possible. Using a driving simulator (a safe and cost-effective alternative with no impact on licensing for participants), this study will investigate the feasibility and preliminary efficacy of utilizing in-vehicle technology (i.e., a simulated lane change assistance system) to address critical driving errors in individuals with mild to moderate Parkinson's disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lane change assistance system | This study will investigate the feasibility and preliminary efficacy of a 6-session lane change ADAS-intervention on the simulated driving performance of individuals with mild to moderate PD. We anticipate that the use of lane change assist technology will decrease the number of driving errors in individuals with PD. As this is a feasibility study, we will evaluate: -recruitment capability and sample characteristics - data collection methods, procedures, and outcome measures - acceptability and suitability of the lane change assist technology intervention - preliminary efficacy The outcomes of this study will inform the design of a larger study, should such large-scale study be warranted. |
| BEHAVIORAL | Active Control | Participants will practice their driving on a driving simulator with feedback form a trained interventionist. |
Timeline
- Start date
- 2019-04-15
- Primary completion
- 2022-12-30
- Completion
- 2022-12-31
- First posted
- 2017-06-22
- Last updated
- 2024-03-04
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03195608. Inclusion in this directory is not an endorsement.